RankingsPricing
  1. JP-listed companies
  2. Sumitomo Pharma Co., Ltd.
  3. Financials
  4. Net income

Sumitomo Pharma Co., Ltd.【JP:4506】

Market cap
¥1.16T
P/E ratio
12.6x
SummaryFinancialsDividendsHistorySegmentsOwnershipWorkforce
Period EndNet income (Million JPY)YoY (%)
Mar 31, 202523,634-107.50%
Mar 31, 2024-314,969+322.71%
Mar 31, 2023-74,512-232.08%
Mar 31, 202256,413+0.35%
Mar 31, 202156,219+37.95%
Mar 31, 202040,753-16.19%
Mar 31, 201948,627-9.02%
Mar 31, 201853,448+84.36%
Mar 31, 201728,991+17.39%
Mar 31, 201624,697+59.88%
Mar 31, 201515,447+1.56%
Mar 31, 201415,210+33.94%
Mar 31, 201311,356-48.52%
Mar 31, 201222,058

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)